No Data
No Data
No Data
No Data
No Data
Is It Too Late To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?
Yahoo FinanceMar 31 18:33 ET
AU Morning Wrap: ASX Shares Hit Record High, Miners Jump
Stocks to watch: Ramsay Health Care, Mineral Resources.
Moomoo News AUMar 27 19:39 ET
Australian Clinical Labs Target Price Cut 6.9% to A$3.35/Share by Citi>ACL.AU
Australian Clinical Labs Target Price Cut 6.9% to A$3.35/Share by Citi>ACL.AU
Dow JonesFeb 28 16:22 ET
2 ASX 300 Shares Crashing up to 12% on Earnings Updates
Listed below are two ASX 300 shares that are being sold off following the release of their respective releases.
The Motley FoolFeb 27 22:36 ET
Australian Clinical Labs Slashes Interim Dividend as Underlying H1 FY24 EPS Falls 49%
Australian Clinical Labs (ASX:ACL) reported Wednesday that its underlying earnings per share in the six-month period ended Dec. 31, 2023, were down 49% year over year to AU$0.0511. Statutory EPS fell
MT NewswiresFeb 27 17:31 ET
Australian Clinical Labs Interim Dividend 3 Australian Cents/Security
Australian Clinical Labs Interim Dividend 3 Australian Cents/Security
Dow JonesFeb 27 16:10 ET
No Data
No Data